[1] LEISSINGER C.Another victory for patients with hemophilia[J].N Engl J Med,2023,388(4):372-373. [2] 樊凤艳,汪德清.我国临床输血发展的挑战与思考[J].临床输血与检验,2021,23(1):10-12. [3] 何欢,阙文君,余泽波.血浆输注的临床应用及管理研究进展[J].重庆医学,2023,52(12):1898-1902. [4] DRAKE R,JACKSON B P,MURPHY C H.Single plasma unit transfusions in adults are either unnecessary or underdosed[J].Am J Clin Pathol,2022,158(1):148-152. [5] GOEL R,CHAPPIDI M R,PATEL E U,et al.Trends in red blood cell,plasma,and platelet transfusions in the United States,1993-2014[J].JAMA,2018,319(8):825-827. [6] 中华人民共和国国家卫生健康委员会.全血和成分血使用[S].2018. [7] 周吉成,于洋,夏荣,等.输血相关急性肺损伤诊治中国专家共识(2023版)[J].临床输血与检验,2023,25(5):577-585. [8] BISCOPING J.Therapy with blood components and plasma derivatives:the current cross-sectional guidelines[J].Anaesthesist,2009,58(11):1083-1084. [9] HO A M H,DION P W,YEUNG J H H,et al.Prevalence of survivor bias in observational studies on fresh frozen plasma:erythrocyte ratios in trauma requiring massive transfusion[J].Anesthesiology,2012,116(3):716-728. [10] MITRA B,JORGENSEN M,READE M C,et al.Patient blood management guideline for adults with critical bleeding[J]. Med J Aust,2024,220(4):211-216. [11] GREEN L,BOLTON-MAGGS P,BEATTIE C,et al.British Society of Haematology Guidelines on the spectrum of fresh frozen plasma and cryoprecipitate products:their handling and use in various patient groups in the absence of major bleeding (Br J Haematol.2018;181:54-67).Addendum August 2020[J].Br J Haematol,2020,191(5):728-729. [12] KUJOVICH J L.Hemostatic defects in end stage liver disease[J].Crit Care Clin,2005,21(3):563-587. [13] VLAAR A P J,DIONNE J C,DE BRUIN S,et al.Transfusion strategies in bleeding critically ill adults:a clinical practice guideline from the European Society of Intensive Care Medicine[J].Intensive Care Med,2021,47(12):1368-1392. [14] ROBACK J D,CALDWELL S,CARSON J,et al.Evidence-based practice guidelines for plasma transfusion[J].Transfusion,2010,50(6):1227-1239. [15] O'SHAUGHNESSY D F,ATTERBURY C,BOLTON MAGGS P,et al.Guidelines for the use of fresh-frozen plasma,cryoprecipitate and cryosupernatant[J].Br J Haematol,2004,126(1):11-28. [16] XU G P,WU L F,XU X M,et al.Information technology improves the quality of transfusion practice in China[J].Vox Sang,2023,118(2):138-146. [17] ZHU C T,GAO Y L,LI Z Q,et al.A systematic review and meta-analysis of the clinical appropriateness of blood transfusion in China[J].Medicine (Baltimore),2015,94(50):e2164. [18] 聂志扬,赵学彬,马婉茹,等.2020年全国临床用血质量控制指标调研分析[J].临床输血与检验,2023,25(4):514-517. [19] HSU L I,CHEN J W,LIN D T,et al.The continued decline of plasma transfusions in Taiwan:an 11-year population-based study[J].Vox Sang,2022,117(4):535-544. [20] BEVERINA I,NOVELLI C,GATTI A,et al.Efficacy of a strict surveillance policy towards inappropriateness of plasma transfusion[J].Transfus Apher Sci, 2019,58(4):423-428. [21] SEHEULT J N,SHAZ B,BRAVO M,et al.Changes in plasma unit distributions to hospitals over a 10-year period[J].Transfusion,2018,58(4):1012-1020. [22] QIANG J K,THOMPSON T,CALLUM J,et al.Variations in RBC and frozen plasma utilization rates across 62 Ontario community hospitals[J].Transfusion,2019,59(2):545-554. [23] KHANDELWAL A,MINUK L,LIU Y,et al.Plasma transfusion practices:a multicentre electronic audit[J].Vox Sang,2022,117(10):1211-1219. [24] ELLINGSON K D,SAPIANO M R P,HAASS K A,et al.Continued decline in blood collection and transfusion in the United States-2015[J].Transfusion,2017,57(S2):1588-1598. [25] LU W.A concise synopsis of current literature and guidelines on the practice of plasma transfusion[J].Clin Lab Med,2021,41(4):635-645. [26] DAVENPORT P,SOLA-VISNER M.Hemostatic challenges in neonates[J].Front Pediatr,2021,9:627715. [27] FERRADA P,JACOBS L M.“Resuscitation of the exsanguinating trauma patient:Prioritize circulation and stop the bleed”[J]. Am J Surg,2023,226(2):294-295. [28] TUCKER H,BROHI K,TAN J,et al.Association of red blood cells and plasma transfusion versus red blood cell transfusion only with survival for treatment of major traumatic hemorrhage in prehospital setting in England:a multicenter study[J]. Crit Care,2023,27(1):25. [29] HOLCOMB J B,TILLEY B C,BARANIUK S,et al.Transfusion of plasma,platelets,and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma:the PROPPR randomized clinical trial[J]. JAMA,2015,313(5):471-482. [30] BORGMAN M A,SPINELLA P C,PERKINS J G,et al.The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital[J]. J Trauma,2007,63(4):805-813. [31] SHAYLOR R,WEINIGER C F,AUSTIN N,et al.National and international guidelines for patient blood management in obstetrics:a qualitative review[J]. Anesth Analg,2017,124(1):216-232. [32] ARNI D,WILDHABER B E,MCLIN V,et al.Effects of plasma transfusions on antithrombin levels after paediatric liver transplantation[J]. Vox Sang,2018,113(6):569-576. [33] PARKER J E,MARTINEZ A,DEUTSCH G K,et al.Safety of plasma infusions in Parkinson’s disease[J]. Mov Disord,2020,35(11):1905-1913. [34] HANNESTAD J,DUCLOS T,CHAO W,et al.Safety and tolerability of GRF6019 infusions in severe Alzheimer’s disease:a phase II double-blind placebo-controlled trial[J]. J Alzheimers Dis,2021,81(4):1649-1662. [35] DANI C,POGGI C,BRESCI C,et al.Early fresh-frozen plasma transfusion decreases the risk of retinopathy of prematurity[J]. Transfusion,2014,54(4):1002-1007. [36] BAUER P R,OSTERMANN M,RUSSELL L,et al.Plasma exchange in the intensive care unit:a narrative review[J]. Intensive Care Med,2022,48(10):1382-1396. [37] CERVANTES C E,BLOCH E M,SPERATI C J.Therapeutic plasma exchange:core curriculum 2023[J]. Am J Kidney Dis,2023,81(4):475-492. [38] JR V V M. Acquired autoimmune thrombotic thrombocytopenic purpura[J]. Nursing,2019,49(1):22-29. [39] EPSTEIN M A,SLADKY J T.The role of plasmapheresis in childhood Guillain-Barré syndrome[J]. Ann Neurol,1990,28(1):65-69. [40] CLARK W F,HUANG S H S,WALSH M W,et al. Plasmapheresis for the treatment of kidney diseases[J]. Kidney Int,2016,90(5):974-984. [41] SEXTON D J.Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis[J]. N Engl J Med,2020,382(22):2168. [42] XING Y D,WANG S Q,LIU C Y,et al.Efficacy and safety of dual filtration plasmapheresis combined with biological agents in active refractory rheumatod arthritis[J].Medicine,2020,99(28):e20966. [43] ZHANG F,ZHANG B Y,FAN R,et al.Clinical efficacy of plasma exchange in systemic lupus erythematosus during pregnancy[J].Immunity Inflam & Disease,2023,11(10): e1041. [44] TIAN X,KONG Y J,WANG J,et al.Development of the Chinese Haemovigilance Network and reporting of adverse transfusion reactions from 2018 to 2020[J]. Vox Sang,2022,117(8):1027-1034. [45] VAN DEN BRINK D P,KLEINVELD D J B,SLOOS P H,et al. Plasma as a resuscitation fluid for volume-depleted shock:potential benefits and risks[J]. Transfusion,2021,61(Suppl 1):S301-S312. [46] GÖRLINGER K,SANER F H. Prophylactic plasma and platelet transfusion in the critically Ill patient:just useless and expensive or even harmful?[J]. BMC Anesthesiol,2015,15:86. [47] CLIFFORD L,JIA Q,SUBRAMANIAN A,et al.Characterizing the epidemiology of postoperative transfusion-related acute lung injury[J]. Anesthes-iology,2015,122(1):12-20. [48] KLANDERMAN R B,VAN MOURIK N,EGGERMONT D,et al.Incidence of transfusion-related acute lung injury temporally associated with solvent/detergent plasma use in the ICU:a retrospective before and after implementation study[J]. Transfusion,2022,62(9):1752-1762. [49] OLSEN G,PASSWATER M,HUGGINS M,et al.Evaluation of A plasma for incompatible patients[J]. Transfusion,2021,61(2):375-378. [50] ADAM E H,FISCHER D.Plasma transfusion practice in adult surgical patients:systematic review of the literature[J]. Transfus Med Hemother,2020,47(5):347-359. [51] BOSBOOM J J,KLANDERMAN R B,ZIJP M,et al.Incidence,risk factors,and outcome of transfusion-associated circulatory overload in a mixed intensive care unit population:a nested case-control study[J]. Transfusion,2018,58(2):498-506. [52] THALJI L,THUM D,WEISTER T J,et al.Incidence and epidemiology of perioperative transfusion-related pulmonary complications in pediatric noncardiac surgical patients:a single-center,5-year experience[J].Anesth Analg,2018,127(5):1180-1188. [53] TUNG J P,CHIARETTI S,DEAN M M,et al.Trans-fusion-related acute lung injury (TRALI):potential pathways of development,strategies for prevention and treatment,and future research directions[J]. Blood Rev,2022,53:100926. [54] KLANDERMAN R B,BULLE E B,HEIJNEN J W M,et al. Reported transfusion-related acute lung injury associated with solvent/detergent plasma - A case series[J]. Transfusion,2022,62(3):594-599. [55] GILSTAD C W.Anaphylactic transfusion reactions[J]. Curr Opin Hematol,2003,10(6):419-423. [56] MERDJI H,CLERE-JEHL R,MONNIER A,et al.Yellow urticaria following plasma transfusion[J]. Intensive Care Med,2018,44(1):100-101. [57] SARANI B,DUNKMAN W J,DEAN L,et al.Transfusion of fresh frozen plasma in critically ill surgical patients is associated with an increased risk of infection[J]. Crit Care Med,2008,36(4):1114-1118. [58] MCVEY M J,KAPUR R,CSERTI-GAZDEWICH C,et al.Transfusion-related acute lung injury in the periop erative patient[J]. Anesthesiology,2019,131(3): 693-715. [59] JIA Q,BROWN M J,CLIFFORD L,et al.Prophylactic plasma transfusion for surgical patients with abnormal preoperative coagulation tests:a single-institution propensity-adjusted cohort study[J]. Lancet Haematol,2016,3(3):e139-e148. [60] SOKOU R,PARASTATIDOU S,KONSTANTINIDI A,et al.Fresh frozen plasma transfusion in the neonatal population:a systematic review[J].Blood Rev,2022,55:100951. [61] VIGNOLI A,TENORI L,MORSIANI C,et al.Serum or plasma (and which plasma),that is the question[J]. J Proteome Res,2022,21(4):1061-1072. |